Skip to main content
OpenTrials
Completed

NCT Number: NCT01192958

A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza

At present influenza immunity can only be reliably confirmed by a blood test. This test is invasive for the patient. This study is intended to validate an oral fluid/saliva antibody test for the variant Swine Influenza H1N1. If such a test were available, this painless and non invasive test will improve direct clinical care to an individual as well as significantly help guide future public health management of the pandemic.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants of the clinical service evaluation of novel H1N1v vaccine
  • First or second blood sample for the clinical service evaluation successfully collected

Exclusion criteria

  • Withdrawn from clinical service evaluation of novel H1N1v vaccine
  • Second blood sample for the clinical service evaluation not collected.

Sponsors and collaborators

Lead sponsor

Public Health England

Other Gov

Registry information

Acronym: Snuffles

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Sep 1, 2010
Registry last updated
Sep 1, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.